Tim is Professor of Retinal Research at King’s College London, the UK’s largest biomedical sciences university. His key research interest is the investigation of novel drugs and surgical devices for retinal disease, particularly age-related macular degeneration (AMD) and diabetic eye disease.
Clinical trials and grants
Tim is Chief Investigator on a number of national and international trials, with a research portfolio totalling approximately £6M.
Examples of trials that Tim leads include:
STAR: a 28-centre, randomised, double-masked, sham-controlled, device trial of the robotically controlled delivery of stereotactic radiotherapy for wet AMD, funded by the NIHR. Details available here.
TIGER: a pan-European, randomised, controlled, surgical trial of vitrectomy, tissue plasminogen activator and gas tamponade for submacular haemorrhage secondary to wet AMD, commissioned by Euretina and funded by Fight for Sight. Details available here.
‘Bionic eye’: Tim served as a Principal Investigator in a clinical trial of subretinal implants for the treatment of retinitis pigmentosa. Details available at The BBC.
28 Web of Science
36 Google Scholar (October 2020)
Supervision of higher degrees
Tim supervises doctors studying for MD(Research) and PhDs.
If you are patient and want to find out more about participating in a clinical trial, an investigator exploring collaborations, or a GMC-registered clinician wanting to register for a higher degree please contact Professor Jackson’s Research Office on 020 3299 1297.